President-elect Joe Biden plans on Monday to name a 12-member coronavirus task force to be co-chaired by former Surgeon General Vivek Murthy, according to several media reports citing anonymous sources.
The immediate focus on creating a task force as part of Biden’s transition planning underscored his concern about COVID-19, which has killed nearly 250,000 Americans this year. The number of daily cases in the nation is spiking by record amounts; more than 125,000 cases were reported on Friday.
Task force members have already begun advising Biden on public policy concerning the pandemic and on safety protocols for his campaign.
Trump has taken far less interest in his own coronavirus task force for several weeks and has sidestepped and even criticized advice from respected infectious disease expert Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases.
Instead, Trump has focused on suggestions from his new health adviser, Scott Atlas, a neuroradiologist with no background in infectious diseases. Atlas believes that COVID-19 should be allowed to spread among the young and healthy in a push to develop herd immunity — a strategy that infectious disease experts said is ill-advised.
Twitter last month deleted a tweet from Atlas for sharing “misleading information” after he wrote that masks don’t help to stop the spread COVID-19.
Trump suggested at a recent rally that he would “fire” Fauci should he be reelected.
Fauci told The Washington Post last week regarding Atlas, “I have real problems with that guy.” He added: He’s “talking about things that I believe he doesn’t have any real insight or knowledge or experience in. He keeps talking about things that … [don’t] make any sense.”
Fauci added that the nation “could not be positioned more poorly” for fighting the disease now, particularly as Americans head into the winter flu season and spend more time indoors amid colder weather.
Fauci praised Biden for taking COVID-19 “seriously from a public health perspective.” Trump, on the other hand, is focused on the “economy and opening businesses,” he said.
Trump in May named former pharmaceutical company executive Moncef Slaoui to lead a vaccine push for the federal government. Slaoui announced he would divest millions of dollars from companies linked to vaccine development after complaints of a conflict of interest. But he still held stock as recently as September.
A HuffPost Guide To Coronavirus
Calling all HuffPost superfans!
Sign up for membership to become a founding member and help shape HuffPost’s next chapter